122 related articles for article (PubMed ID: 23113888)
1. Who's driving anyway? Herculean efforts to identify the drivers of breast cancer.
Hartmaier RJ; Priedigkeit N; Lee AV
Breast Cancer Res; 2012 Oct; 14(5):323. PubMed ID: 23113888
[TBL] [Abstract][Full Text] [Related]
2. Genomics: the breast cancer landscape.
Gray J; Druker B
Nature; 2012 Jun; 486(7403):328-9. PubMed ID: 22722187
[No Abstract] [Full Text] [Related]
3. The landscape of cancer genes and mutational processes in breast cancer.
Stephens PJ; Tarpey PS; Davies H; Van Loo P; Greenman C; Wedge DC; Nik-Zainal S; Martin S; Varela I; Bignell GR; Yates LR; Papaemmanuil E; Beare D; Butler A; Cheverton A; Gamble J; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; Lau KW; McLaren S; McBride DJ; Menzies A; Mudie L; Raine K; Rad R; Chapman MS; Teague J; Easton D; Langerød A; ; Lee MT; Shen CY; Tee BT; Huimin BW; Broeks A; Vargas AC; Turashvili G; Martens J; Fatima A; Miron P; Chin SF; Thomas G; Boyault S; Mariani O; Lakhani SR; van de Vijver M; van 't Veer L; Foekens J; Desmedt C; Sotiriou C; Tutt A; Caldas C; Reis-Filho JS; Aparicio SA; Salomon AV; Børresen-Dale AL; Richardson AL; Campbell PJ; Futreal PA; Stratton MR
Nature; 2012 May; 486(7403):400-4. PubMed ID: 22722201
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
5. Cancer: Genomics of metastasis.
Gray J
Nature; 2010 Apr; 464(7291):989-90. PubMed ID: 20393550
[No Abstract] [Full Text] [Related]
6. Whole-genome analysis informs breast cancer response to aromatase inhibition.
Ellis MJ; Ding L; Shen D; Luo J; Suman VJ; Wallis JW; Van Tine BA; Hoog J; Goiffon RJ; Goldstein TC; Ng S; Lin L; Crowder R; Snider J; Ballman K; Weber J; Chen K; Koboldt DC; Kandoth C; Schierding WS; McMichael JF; Miller CA; Lu C; Harris CC; McLellan MD; Wendl MC; DeSchryver K; Allred DC; Esserman L; Unzeitig G; Margenthaler J; Babiera GV; Marcom PK; Guenther JM; Leitch M; Hunt K; Olson J; Tao Y; Maher CA; Fulton LL; Fulton RS; Harrison M; Oberkfell B; Du F; Demeter R; Vickery TL; Elhammali A; Piwnica-Worms H; McDonald S; Watson M; Dooling DJ; Ota D; Chang LW; Bose R; Ley TJ; Piwnica-Worms D; Stuart JM; Wilson RK; Mardis ER
Nature; 2012 Jun; 486(7403):353-60. PubMed ID: 22722193
[TBL] [Abstract][Full Text] [Related]
7. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
Zhang W; Wang SL
Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
[TBL] [Abstract][Full Text] [Related]
8. Copy number aberrations define breast cancer subgroups.
Cancer Discov; 2012 Jun; 2(6):OF6. PubMed ID: 22684464
[TBL] [Abstract][Full Text] [Related]
9. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Curtis C; Shah SP; Chin SF; Turashvili G; Rueda OM; Dunning MJ; Speed D; Lynch AG; Samarajiwa S; Yuan Y; Gräf S; Ha G; Haffari G; Bashashati A; Russell R; McKinney S; ; Langerød A; Green A; Provenzano E; Wishart G; Pinder S; Watson P; Markowetz F; Murphy L; Ellis I; Purushotham A; Børresen-Dale AL; Brenton JD; Tavaré S; Caldas C; Aparicio S
Nature; 2012 Apr; 486(7403):346-52. PubMed ID: 22522925
[TBL] [Abstract][Full Text] [Related]
10. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
[TBL] [Abstract][Full Text] [Related]
11. Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer.
Annunziato S; de Ruiter JR; Henneman L; Brambillasca CS; Lutz C; Vaillant F; Ferrante F; Drenth AP; van der Burg E; Siteur B; van Gerwen B; de Bruijn R; van Miltenburg MH; Huijbers IJ; van de Ven M; Visvader JE; Lindeman GJ; Wessels LFA; Jonkers J
Nat Commun; 2019 Jan; 10(1):397. PubMed ID: 30674894
[TBL] [Abstract][Full Text] [Related]
12. LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome.
Ramirez-Ardila DE; Ruigrok-Ritstier K; Helmijr JC; Look MP; van Laere S; Dirix L; Berns EM; Jansen MP
Mol Oncol; 2016 Oct; 10(8):1363-73. PubMed ID: 27491861
[TBL] [Abstract][Full Text] [Related]
13. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
Elife; 2020 May; 9():. PubMed ID: 32401198
[TBL] [Abstract][Full Text] [Related]
14. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution.
Shah SP; Morin RD; Khattra J; Prentice L; Pugh T; Burleigh A; Delaney A; Gelmon K; Guliany R; Senz J; Steidl C; Holt RA; Jones S; Sun M; Leung G; Moore R; Severson T; Taylor GA; Teschendorff AE; Tse K; Turashvili G; Varhol R; Warren RL; Watson P; Zhao Y; Caldas C; Huntsman D; Hirst M; Marra MA; Aparicio S
Nature; 2009 Oct; 461(7265):809-13. PubMed ID: 19812674
[TBL] [Abstract][Full Text] [Related]
15. Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1.
Shibahara Y; Miki Y; Onodera Y; Hata S; Chan MS; Yiu CC; Loo TY; Nakamura Y; Akahira J; Ishida T; Abe K; Hirakawa H; Chow LW; Suzuki T; Ouchi N; Sasano H
J Pathol; 2012 Jul; 227(3):357-66. PubMed ID: 22407818
[TBL] [Abstract][Full Text] [Related]
16. Genome remodelling in a basal-like breast cancer metastasis and xenograft.
Ding L; Ellis MJ; Li S; Larson DE; Chen K; Wallis JW; Harris CC; McLellan MD; Fulton RS; Fulton LL; Abbott RM; Hoog J; Dooling DJ; Koboldt DC; Schmidt H; Kalicki J; Zhang Q; Chen L; Lin L; Wendl MC; McMichael JF; Magrini VJ; Cook L; McGrath SD; Vickery TL; Appelbaum E; Deschryver K; Davies S; Guintoli T; Lin L; Crowder R; Tao Y; Snider JE; Smith SM; Dukes AF; Sanderson GE; Pohl CS; Delehaunty KD; Fronick CC; Pape KA; Reed JS; Robinson JS; Hodges JS; Schierding W; Dees ND; Shen D; Locke DP; Wiechert ME; Eldred JM; Peck JB; Oberkfell BJ; Lolofie JT; Du F; Hawkins AE; O'Laughlin MD; Bernard KE; Cunningham M; Elliott G; Mason MD; Thompson DM; Ivanovich JL; Goodfellow PJ; Perou CM; Weinstock GM; Aft R; Watson M; Ley TJ; Wilson RK; Mardis ER
Nature; 2010 Apr; 464(7291):999-1005. PubMed ID: 20393555
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Molecular Stratification: From Intrinsic Subtypes to Integrative Clusters.
Russnes HG; Lingjærde OC; Børresen-Dale AL; Caldas C
Am J Pathol; 2017 Oct; 187(10):2152-2162. PubMed ID: 28733194
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling.
Li D; Xia H; Li ZY; Hua L; Li L
Biomed Res Int; 2015; 2015():746970. PubMed ID: 25961039
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours.
Ma X; Liu Y; Liu Y; Alexandrov LB; Edmonson MN; Gawad C; Zhou X; Li Y; Rusch MC; Easton J; Huether R; Gonzalez-Pena V; Wilkinson MR; Hermida LC; Davis S; Sioson E; Pounds S; Cao X; Ries RE; Wang Z; Chen X; Dong L; Diskin SJ; Smith MA; Guidry Auvil JM; Meltzer PS; Lau CC; Perlman EJ; Maris JM; Meshinchi S; Hunger SP; Gerhard DS; Zhang J
Nature; 2018 Mar; 555(7696):371-376. PubMed ID: 29489755
[TBL] [Abstract][Full Text] [Related]
20. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]